Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
OncoMab™ GmbH
Download detailed PDF Members: OncoMab™ GmbH's business is the development of human antibodies for the treatment of cancer. The OncoMab™ way is unique because the antibodies are not developed in mice or by genetic engineering, but are isolated directly from cancer patients. The OncoMab™ antibodies are part of the innate natural immunity against malignant cells. This innate immune system functions as the first defence against transformed cells and infections. The human organism has “learned” over millions of years to fight against cancer cells daily. OncoMab™ is using this “immune source” to isolate “nature's best weapons” for targeted antibody therapy and to define new tumor targets
This page has been viewed 355 times since April 2007, the link to the organisation's website has been followed 58 times Recent Search Terms used to find this page: Oncomab | oncomab | Oncomab | oncomab gmbh | oncomab | . Search for more companies in Würzburg This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for OncoMab™ GmbH | |||||||||||||||||||||||||||||||||||||||||
|